ONCOLYTICS BIOTECH INC
ONCY
ONCY was delisted on the 4th of November, 2015.
34 hedge funds and large institutions have $7.72M invested in ONCOLYTICS BIOTECH INC in 2014 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 4 closing their positions.
83% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 6
33% more call options, than puts
Call options by funds: $125K | Put options by funds: $94K
0% more funds holding
Funds holding: 34 → 34 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
43% less capital invested
Capital invested by funds: $13.6M → $7.72M (-$5.84M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RFC
Russell Frank Company
Seattle,
Washington
|
+$331K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$25.9K |
| 3 |
Jane Street
New York
|
+$22.6K |
| 4 |
Renaissance Technologies
New York
|
+$17.8K |
| 5 |
Goldman Sachs
New York
|
+$14.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$2.59M |
| 2 |
First Eagle Investment Management
New York
|
-$342K |
| 3 |
Millennium Management
New York
|
-$91K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$36K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$24.6K |
ONCY Hedge Fund Activity: Q2 2014 in Review
34 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in ONCOLYTICS BIOTECH INC (ONCY) for Q2 2014, worth a combined $7.72M — down 43% from $13.6M a quarter earlier.
Fund positioning in ONCY was balanced in Q2 2014: 4 funds opened new positions, 4 closed out, 11 added to existing stakes and 6 trimmed.
The largest buyer was Russell Frank Company, adding an estimated $331K. The largest seller was Bank of Montreal, cutting an estimated $2.59M.
- 34 institutional investors held ONCOLYTICS BIOTECH INC (ONCY) as of Q2 2014, unchanged from Q1 2014.
- Funds reported $7.72M of ONCOLYTICS BIOTECH INC stock for Q2 2014, down 43% quarter-over-quarter.
- 4 funds opened new ONCOLYTICS BIOTECH INC positions in Q2 2014 and 4 closed out, a net change of 0 holders.
- The largest ONCOLYTICS BIOTECH INC buyer in Q2 2014 was Russell Frank Company, an estimated $331K added.
- The largest ONCOLYTICS BIOTECH INC seller in Q2 2014 was Bank of Montreal, an estimated $2.59M sold.
Based on aggregated 13F filings for Q2 2014.